参考文献/References:
[1] Scott RM, Smith ER. Moyamoya disease and moya moya
syndrome [J]. N Engl J Med，2009, 360(12): 1226-1237.
[2] Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease.
Disease showing abnormal net-like vessels in base of brain
[J]. Arch Neurol, 1969, 20(3): 288-299.
[3] Kuroda S, Houkin K. Moyamoya disease: current concepts
and future perspectives [J]. Lancet Neurol, 2008, 7(11):
1056-1066.
[4] Pandey P, Steinberg GK. Neurosurgical advances in the
treatment of moyamoya disease [J]. Stroke, 2011, 42(11):
3304-3310.
[5] Yu J, Shi L, Guo Y, et al. Progress on complications of direct
bypass for Moyamoya Disease [J]. Int J Med Sci, 2016, 13
(8): 578-587.
[6] Hayashi K, Horie N, Suyama K, et al. Incidence and clinical
features of symptomatic cerebral hyperperfusion syndrome
after vascular reconstruction [J]. World Neurosurg, 2012, 78
(5): 447-454.
[7] Fujimura M, Mugikura S, Kaneta T, et al. Incidence and risk
factors for symptomatic cerebral hyperperfusion after super-
ficial temporal artery-middle cerebral artery anastomosis in
patients with moyamoya disease [J]. Surg Neurol, 2009, 71
(4): 442-447.
[8] Uno M, Nakajima N, Nishi K, et al. Hyperperfusion syn-
drome after extracranial-intracranial bypass in a patient
with moyamoya disease--case report [J]. Neurol Med Chir
(Tokyo), 1998, 38(7): 420-424.
[9] Kaku Y, Iihara K, Nakajima N, et al. Cerebral blood flow
and metabolism of hyperperfusion after cerebral revascula-
rization in patients with moyamoya disease [J]. J Cereb
Blood Flow Metab, 2012, 32(11): 2066-2075.
[10] Han JS, Abou-Hamden A, Mandell DM, et al. Impact of
extracranial-intracranial bypass on cerebrovascular reac-
tivity and clinical outcome in patients with symptomatic
moyamoya vasculopathy [J]. Stroke, 2011, 42(11): 3047-
3054.
[11] Uchino H, Kuroda S, Hirata K et al. Predictors and clinical
features of postoperative hyperperfusion after surgical reva-
scularization for moyamoya disease: a serial single photon
emission CT/positron emission tomography study [J]. Stroke,
2012, 43: 2610-2616.
[12] Kang HS, Kim JH, Phi JH, et al. Plasma matrix metallopro
teinases, cytokines and angiogenic factors in moyamoya
disease [J]. J Neurol Neurosurg Psychiatry, 2010, 81(6):
673-678.
[13] Fujimura M, Kaneta T, Mugikura S, et al. Temporary neuro-
logic deterioration due to cerebral hyperperfusion after
superficial temporal artery-middle cerebral artery anasto-
mosis in patients with adult-onset moyamoya disease [J].
Surg Neurol, 2007, 67(3): 273-282.
[14] Fujimura M, Shimizu H, Mugikura S, et al. Delayed intrace-
rebral hemorrhage after superficial temporal artery-middle
cerebral artery anastomosis in a patient with moyamoya
disease: possible involvement of cerebral hyperperfusion
and increased vascular permeability [J]. Surg Neurol, 2009,
71(2): 223-227.
[15] Gesang DZ, Zhang D, Zhao JZ, et al. Laser Doppler flowme-
ter study on regional cerebral blood flow in early stage after
standard superficial temporal artery-middle cerebral artery
bypass surgery for moyamoya disease [J]. Chin Med J (Engl),
2009, 122(20): 2412-2418.
[16] Chen Y, Xu W, Guo X, et al. CT perfusion assessment of
Moyamoya syndrome before and after direct revasculariza-
tion (superficial temporal artery to middle cerebral artery
bypass) [J]. Eur Radiol, 2016, 26(1): 254-261.
[17] Fujimura M, Inoue T, Shimizu H, et al. Efficacy of prophy-
lactic blood pressure lowering according to a standardized
postoperative management protocol to prevent symptomatic
cerebral hyperperfusion after direct revascularization sur-
gery for moyamoya disease [J]. Cerebrovasc Dis, 2012, 33
(5): 436-445.
[18] Uchino H, Nakayama N, Kazumata K, et al. Edaravone
reduces hyperperfusion-related neurological deficits in
adult moyamoya disease: historical control study [J]. Stroke,
2016, 47(7): 1930-1932.
[19] Fujimura M, Niizuma K, Inoue T, et al. Minocycline prevents
focal neurological deterioration due to cerebral hyperper-
fusion after extracranial-intracranial bypass for moyamoya
disease [J]. Neurosurgery, 2014, 74(2): 163-170.
相似文献/References:
[1]李 琴 袁辉胜.高压氧治疗抢救烟雾病合并一氧化碳中毒1例[J].中国临床神经外科杂志,2016,(07):441.[doi:10.13798/j.issn.1009-153X.2016.07.019]
[2]张登文 邓剑平 张 涛 陈 虎 赵振伟.颞浅动脉-颞浅筋膜-脑贴敷术治疗烟雾病疗效观察[J].中国临床神经外科杂志,2015,(06):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
ZHANG Deng-wen,DENG Jian-ping,ZHANG Tao,et al.Curative effect of encephalo-superficial temporal artery-superficial temporal fascia flap-synangiosis on Moyamoya disease (report of 31 cases)[J].,2015,(04):326.[doi:10.13798/j.issn.1009-153X.2015.06.002]
[3]刘锡禹 张正善 赵 峰 韩 聪 李 斌 段 炼.烟雾病合并后循环病变致继发枕叶梗死的相关危险因素分析[J].中国临床神经外科杂志,2015,(07):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
LIU Xi-yu,ZHANG Zheng-shan,ZHAO Feng,et al.Analysis of the risk factors related to occipital lobe infarction induced by Moyamoya disease complicated with posterior circulation lesions[J].,2015,(04):392.[doi:10.13798/j.issn.1009-153X.2015.07.003]
[4]黄 坦 黄书岚 陈谦学.颞浅动脉-大脑中动脉搭桥术治疗成人烟雾病[J].中国临床神经外科杂志,2015,(05):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
HUANG Tan,HUANG Shu-lan,CHEN Qian-xue..Treatment of Moyamoya disease with superficial temporal artery-middle cerebral artery bypass in adults[J].,2015,(04):271.[doi:10.13798/j.issn.1009-153X.2015.05.005]
[5]李 舜 唐晓平 文 军 罗仁国 张 柳 段军伟 彭 华 赵 龙.成人出血型烟雾病合并颅内动脉瘤的诊治及预后分析[J].中国临床神经外科杂志,2017,(04):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
LI Shun,TANG Xiao-ping,WEN Jun,et al.Diagnosis, treatment and prognosis of intracranial aneurysms in adults with hemorrhagic moyamoya disease[J].,2017,(04):213.[doi:10.13798/j.issn.1009-153X.2017.04.002]
[6]马廉亭.建议把“烟雾病”诊断还原为“脑基底异常血管网”症[J].中国临床神经外科杂志,2017,(07):449.[doi:10.13798/j.issn.1009-153X.2017.07.001]
[7]陈姣红 刘东媛 张红波 李明昌 熊晓星 陈谦学.成人出血型烟雾病围手术期护理观察[J].中国临床神经外科杂志,2018,(06):437.[doi:10.13798/j.issn.1009-153X.2018.06.020]
[8]杨允东 李永强.多普勒超声血流动力学监测在烟雾病STA-MCA吻合术中的应用[J].中国临床神经外科杂志,2018,(07):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
YANG Yun-dong,LI Yong-qiang..Change in the STA hymodynamics monitored by color Doppler ultrasound before and after STA-MCA anastomosis in patients with Moyamoya disease[J].,2018,(04):476.[doi:10.13798/j.issn.1009-153X.2018.07.008]
[9]欧阳光 黄书岚.烟雾病的现况及研究进展[J].中国临床神经外科杂志,2018,(08):564.[doi:doi:10.13798/j.issn.1009-153X.2018.08.020]
[10]黄彩菲,刘雅静,张红波,等.烟雾病血运重建术中配合及护理[J].中国临床神经外科杂志,2018,(10):692.[doi:10.13798/j.issn.1009-153X.2018.10.018]
[11]孙登彬 糜相明 刘运振.磁共振灌注成像在烟雾病血管重建术中的临床应用价值[J].中国临床神经外科杂志,2019,(02):78.[doi:10.13798/j.issn.1009-153X.2019.02.005]
SUN Deng-bin,MI Xiang-ming,LIU Yun-zhen. Department of Neurosurgery,et al.Clinical value of brain MR perfusion-weighted imaging before and after revascularization in patients with moyamoya disease[J].,2019,(04):78.[doi:10.13798/j.issn.1009-153X.2019.02.005]